1 Liimatainen S, "The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures" 16 : 134-141, 2009
2 Arnson Y, "The antiphospholipid syndrome as a neurological disease" 40 : 97-108, 2010
3 Constantin T, "Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy" 15 : CR164-CR169, 2009
4 Cimaz R, "Prevalence of anti-cardiolipin, anti-β2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy" 43 : 52-59, 2002
5 Verrot D, "Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy" 103 : 33-37, 1997
6 Angelini L, "Partial seizures associated with antiphospholipid antibodies in childhood" 29 : 249-253, 1998
7 Agmon-Levin N, "International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies" 73 : 17-23, 2014
8 Eriksson K, "High prevalence of antiphospholipid antibodies in children with epilepsy : a controlled study of 50 cases" 46 : 129-137, 2001
9 Julian T, "Gluten sensitivity and epilepsy : a systematic review" 266 : 1557-1565, 2019
10 Specchio N, "Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis" 32 : 51-56, 2010
1 Liimatainen S, "The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures" 16 : 134-141, 2009
2 Arnson Y, "The antiphospholipid syndrome as a neurological disease" 40 : 97-108, 2010
3 Constantin T, "Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy" 15 : CR164-CR169, 2009
4 Cimaz R, "Prevalence of anti-cardiolipin, anti-β2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy" 43 : 52-59, 2002
5 Verrot D, "Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy" 103 : 33-37, 1997
6 Angelini L, "Partial seizures associated with antiphospholipid antibodies in childhood" 29 : 249-253, 1998
7 Agmon-Levin N, "International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies" 73 : 17-23, 2014
8 Eriksson K, "High prevalence of antiphospholipid antibodies in children with epilepsy : a controlled study of 50 cases" 46 : 129-137, 2001
9 Julian T, "Gluten sensitivity and epilepsy : a systematic review" 266 : 1557-1565, 2019
10 Specchio N, "Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis" 32 : 51-56, 2010
11 Dlott JS, "Drug-induced lupus anticoagulants and antiphospholipid antibodies" 14 : 71-78, 2012
12 Rumsey DG, "Diagnosis and treatment of antiphospholipid syndrome in childhood : a review" 67 : 34-40, 2017
13 Graf J, "Central nervous system manifestations of antiphospholipid syndrome" 43 : 547-560, 2017
14 Brey RL, "Antiphospholipid antibodies and the brain : a consensus report" 20 : 153-157, 2011
15 Peltola JT, "Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders" 109 : 712-717, 2000